AIC
CRDF icon

AWM Investment Company’s Cardiff Oncology CRDF Stock Holding History

AWM Investment Company’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-106,435
Closed -$462K – 97
2024
Q4 		$462K Buy
+106,435
New +$333K 0.06% 82

Other funds holding CRDF

CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

AWM Investment Company's CRDF Position: Q1 2025 in Review

AWM Investment Company sold out of Cardiff Oncology (CRDF) in Q1 2025, closing a stake of 106,435 shares — an estimated $462K sold.

AWM Investment Company first reported a position in CRDF in Q4 2024 and held it in 1 quarter. The position peaked at $462K in Q4 2024. 116 funds tracked by Wall St. Rank hold CRDF as of Q1 2025.

  • AWM Investment Company reported no remaining Cardiff Oncology position as of Q1 2025 after selling out during the quarter.
  • AWM Investment Company sold 106,435 Cardiff Oncology shares in Q1 2025, an estimated $462K.
  • AWM Investment Company first reported a position in Cardiff Oncology in Q4 2024 and held it in 1 quarter.
  • AWM Investment Company's Cardiff Oncology position peaked at $462K in Q4 2024.
  • 116 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2025.

Based on AWM Investment Company's 13F filing for Q1 2025, filed 15 May 2025.